APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Anti-Infective Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global OTC Anti-Infective Products Industry Growth and Trends Forecast to 2032

28 December 2025114 pages

Choose your research edition.

Industry ResearchOTC Anti-Infective Products Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Anti-Infective Products Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal OTC Anti-Infective Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Anti-Infective Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Anti-Infective Products Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Anti-Infective Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Anti-Infective Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Anti-Infective Products include Teva, Johnson & Johnson, NOVARTIS, MYLAN, Roche, Lingrui, Pfizer, CR SANJIU and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global OTC Anti-Infective Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The OTC Anti-Infective Products market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Anti-Infective Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Anti-Infective Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global OTC Anti-Infective Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

OTC Anti-Infective Products Market by Company

Teva

Johnson & Johnson

NOVARTIS

MYLAN

Roche

Lingrui

Pfizer

CR SANJIU

GSK

Bayer

Sun Pharma

Gilead Sciences

Cipla

Bausch Health

Astellas Pharma

OTC Anti-Infective Products Segment by Type

Antiviral

Antibacterial

Antifungal

Antiseptics

Others

OTC Anti-Infective Products Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

OTC Anti-Infective Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of OTC Anti-Infective Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antiviral Table 2. Major Company of Antibacterial Table 3. Major Company of Antifungal Table 4. Major Company of Antiseptics Table 5. Major Company of Others Table 6. Global OTC Anti-Infective Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 8. Global OTC Anti-Infective Products Sales Market Share in Volume by Type (2021-2026) Table 9. Global OTC Anti-Infective Products Sales by Type (2021-2026) & (US$ Million) Table 10. Global OTC Anti-Infective Products Sales Market Share in Value by Type (2021-2026) Table 11. Global OTC Anti-Infective Products Price by Type (2021-2026) & (US$/Unit) Table 12. Global OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 13. Global OTC Anti-Infective Products Sales Market Share in Volume by Type (2027-2032) Table 14. Global OTC Anti-Infective Products Sales by Type (2027-2032) & (US$ Million) Table 15. Global OTC Anti-Infective Products Sales Market Share in Value by Type (2027-2032) Table 16. Global OTC Anti-Infective Products Price by Type (2027-2032) & (US$/Unit) Table 17. North America OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 18. North America OTC Anti-Infective Products Sales by Type (2021-2026) & (US$ Million) Table 19. Europe OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 20. Europe OTC Anti-Infective Products Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 22. Asia-Pacific OTC Anti-Infective Products Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 24. Latin America OTC Anti-Infective Products Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 26. Middle East and Africa OTC Anti-Infective Products Sales by Type (2021-2026) & (US$ Million) Table 27. OTC Anti-Infective Products Industry Trends Table 28. OTC Anti-Infective Products Industry Drivers Table 29. OTC Anti-Infective Products Industry Opportunities and Challenges Table 30. OTC Anti-Infective Products Industry Restraints Table 31. Global OTC Anti-Infective Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global OTC Anti-Infective Products Revenue Market Share by Company (2021-2026) Table 33. Global OTC Anti-Infective Products Sales by Company (2021-2026) & (M Units) Table 34. Global OTC Anti-Infective Products Sales Share by Company (2021-2026) Table 35. Global OTC Anti-Infective Products Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global OTC Anti-Infective Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global OTC Anti-Infective Products Major Company Production Sites and Headquarters Table 38. Global OTC Anti-Infective Products Company, Product Type & Application Table 39. Global OTC Anti-Infective Products Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global OTC Anti-Infective Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global OTC Anti-Infective Products Sales by Region (2021-2026) & (M Units) Table 44. Global OTC Anti-Infective Products Sales Market Share in Volume by Region (2021-2026) Table 45. Global OTC Anti-Infective Products Sales by Region (2021-2026) & (US$ Million) Table 46. Global OTC Anti-Infective Products Sales Market Share in Value by Region (2021-2026) Table 47. Global OTC Anti-Infective Products Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global OTC Anti-Infective Products Sales by Region (2027-2032) & (M Units) Table 49. Global OTC Anti-Infective Products Sales Market Share in Volume by Region (2027-2032) Table 50. Global OTC Anti-Infective Products Sales by Region (2027-2032) & (US$ Million) Table 51. Global OTC Anti-Infective Products Sales Market Share in Value by Region (2027-2032) Table 52. Global OTC Anti-Infective Products Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global OTC Anti-Infective Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 55. Global OTC Anti-Infective Products Sales Market Share in Volume by Application (2021-2026) Table 56. Global OTC Anti-Infective Products Sales by Application (2021-2026) & (US$ Million) Table 57. Global OTC Anti-Infective Products Sales Market Share in Value by Application (2021-2026) Table 58. Global OTC Anti-Infective Products Price by Application (2021-2026) & (US$/Unit) Table 59. Global OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 60. Global OTC Anti-Infective Products Sales Market Share in Volume by Application (2027-2032) Table 61. Global OTC Anti-Infective Products Sales by Application (2027-2032) & (US$ Million) Table 62. Global OTC Anti-Infective Products Sales Market Share in Value by Application (2027-2032) Table 63. Global OTC Anti-Infective Products Price by Application (2027-2032) & (US$/Unit) Table 64. North America OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 65. North America OTC Anti-Infective Products Sales by Application (2021-2026) & (US$ Million) Table 66. Europe OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 67. Europe OTC Anti-Infective Products Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 69. Asia-Pacific OTC Anti-Infective Products Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 71. Latin America OTC Anti-Infective Products Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 73. Middle East and Africa OTC Anti-Infective Products Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Teva OTC Anti-Infective Products Product Portfolio Table 78. Teva Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Johnson & Johnson OTC Anti-Infective Products Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. NOVARTIS Company Information Table 85. NOVARTIS Business Overview Table 86. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. NOVARTIS OTC Anti-Infective Products Product Portfolio Table 88. NOVARTIS Recent Development Table 89. MYLAN Company Information Table 90. MYLAN Business Overview Table 91. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. MYLAN OTC Anti-Infective Products Product Portfolio Table 93. MYLAN Recent Development Table 94. Roche Company Information Table 95. Roche Business Overview Table 96. Roche OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Roche OTC Anti-Infective Products Product Portfolio Table 98. Roche Recent Development Table 99. Lingrui Company Information Table 100. Lingrui Business Overview Table 101. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lingrui OTC Anti-Infective Products Product Portfolio Table 103. Lingrui Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Pfizer OTC Anti-Infective Products Product Portfolio Table 108. Pfizer Recent Development Table 109. CR SANJIU Company Information Table 110. CR SANJIU Business Overview Table 111. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. CR SANJIU OTC Anti-Infective Products Product Portfolio Table 113. CR SANJIU Recent Development Table 114. GSK Company Information Table 115. GSK Business Overview Table 116. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. GSK OTC Anti-Infective Products Product Portfolio Table 118. GSK Recent Development Table 119. Bayer Company Information Table 120. Bayer Business Overview Table 121. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Bayer OTC Anti-Infective Products Product Portfolio Table 123. Bayer Recent Development Table 124. Sun Pharma Company Information Table 125. Sun Pharma Business Overview Table 126. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sun Pharma OTC Anti-Infective Products Product Portfolio Table 128. Sun Pharma Recent Development Table 129. Gilead Sciences Company Information Table 130. Gilead Sciences Business Overview Table 131. Gilead Sciences OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Gilead Sciences OTC Anti-Infective Products Product Portfolio Table 133. Gilead Sciences Recent Development Table 134. Cipla Company Information Table 135. Cipla Business Overview Table 136. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Cipla OTC Anti-Infective Products Product Portfolio Table 138. Cipla Recent Development Table 139. Bausch Health Company Information Table 140. Bausch Health Business Overview Table 141. Bausch Health OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Bausch Health OTC Anti-Infective Products Product Portfolio Table 143. Bausch Health Recent Development Table 144. Astellas Pharma Company Information Table 145. Astellas Pharma Business Overview Table 146. Astellas Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Astellas Pharma OTC Anti-Infective Products Product Portfolio Table 148. Astellas Pharma Recent Development Table 149. North America OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 150. North America OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 151. North America OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 152. North America OTC Anti-Infective Products Sales Forecast by Country (2027-2032) & (M Units) Table 153. North America OTC Anti-Infective Products Sales Market Share Forecast by Country (2027-2032) Table 154. North America OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America OTC Anti-Infective Products Market Size by Country (2021-2026) & (US$ Million) Table 156. North America OTC Anti-Infective Products Market Share by Country (2021-2026) Table 157. North America OTC Anti-Infective Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America OTC Anti-Infective Products Market Share Forecast by Country (2027-2032) Table 159. Europe OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 160. Europe OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 161. Europe OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 162. Europe OTC Anti-Infective Products Sales Forecast by Country (2027-2032) & (M Units) Table 163. Europe OTC Anti-Infective Products Sales Market Share Forecast by Country (2027-2032) Table 164. Europe OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe OTC Anti-Infective Products Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe OTC Anti-Infective Products Market Share by Country (2021-2026) Table 167. Europe OTC Anti-Infective Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe OTC Anti-Infective Products Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 171. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific OTC Anti-Infective Products Sales Forecast by Country (2027-2032) & (M Units) Table 173. Asia-Pacific OTC Anti-Infective Products Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific OTC Anti-Infective Products Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific OTC Anti-Infective Products Market Share by Country (2021-2026) Table 177. Asia-Pacific OTC Anti-Infective Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific OTC Anti-Infective Products Market Share Forecast by Country (2027-2032) Table 179. Latin America OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 180. Latin America OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 181. Latin America OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 182. Latin America OTC Anti-Infective Products Sales Forecast by Country (2027-2032) & (M Units) Table 183. Latin America OTC Anti-Infective Products Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America OTC Anti-Infective Products Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America OTC Anti-Infective Products Market Share by Country (2021-2026) Table 187. Latin America OTC Anti-Infective Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America OTC Anti-Infective Products Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 191. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa OTC Anti-Infective Products Sales Forecast by Country (2027-2032) & (M Units) Table 193. Middle East and Africa OTC Anti-Infective Products Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa OTC Anti-Infective Products Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa OTC Anti-Infective Products Market Share by Country (2021-2026) Table 197. Middle East and Africa OTC Anti-Infective Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa OTC Anti-Infective Products Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. OTC Anti-Infective Products Distributors List Table 202. OTC Anti-Infective Products Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. OTC Anti-Infective Products Image Figure 2. Global OTC Anti-Infective Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Anti-Infective Products Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Anti-Infective Products Sales (2021-2032) & (M Units) Figure 5. Antiviral Image Figure 6. Global Antiviral Sales YoY Growth (2021-2032) & (M Units) Figure 7. Antibacterial Image Figure 8. Global Antibacterial Sales YoY Growth (2021-2032) & (M Units) Figure 9. Antifungal Image Figure 10. Global Antifungal Sales YoY Growth (2021-2032) & (M Units) Figure 11. Antiseptics Image Figure 12. Global Antiseptics Sales YoY Growth (2021-2032) & (M Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 15. Global OTC Anti-Infective Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global OTC Anti-Infective Products Market Share by Type 2025 VS 2032 Figure 17. North America OTC Anti-Infective Products Sales Market Share in Volume by Type in 2025 Figure 18. North America OTC Anti-Infective Products Sales Market Share in Value by Type in 2025 Figure 19. Europe OTC Anti-Infective Products Sales Market Share in Volume by Type in 2025 Figure 20. Europe OTC Anti-Infective Products Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific OTC Anti-Infective Products Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific OTC Anti-Infective Products Sales Market Share in Value by Type in 2025 Figure 23. Latin America OTC Anti-Infective Products Sales Market Share in Volume by Type in 2025 Figure 24. Latin America OTC Anti-Infective Products Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa OTC Anti-Infective Products Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa OTC Anti-Infective Products Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 OTC Anti-Infective Products Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (M Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (M Units) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (M Units) Figure 35. Global OTC Anti-Infective Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global OTC Anti-Infective Products Market Share by Application 2025 VS 2032 Figure 37. North America OTC Anti-Infective Products Sales Market Share in Volume by Application in 2025 Figure 38. North America OTC Anti-Infective Products Sales Market Share in Value by Application in 2025 Figure 39. Europe OTC Anti-Infective Products Sales Market Share in Volume by Application in 2025 Figure 40. Europe OTC Anti-Infective Products Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific OTC Anti-Infective Products Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific OTC Anti-Infective Products Sales Market Share in Value by Application in 2025 Figure 43. Latin America OTC Anti-Infective Products Sales Market Share in Volume by Application in 2025 Figure 44. Latin America OTC Anti-Infective Products Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa OTC Anti-Infective Products Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa OTC Anti-Infective Products Sales Market Share in Value by Application in 2025 Figure 47. North America OTC Anti-Infective Products Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. North America OTC Anti-Infective Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America OTC Anti-Infective Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America OTC Anti-Infective Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe OTC Anti-Infective Products Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Europe OTC Anti-Infective Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe OTC Anti-Infective Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe OTC Anti-Infective Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific OTC Anti-Infective Products Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Asia-Pacific OTC Anti-Infective Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific OTC Anti-Infective Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific OTC Anti-Infective Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America OTC Anti-Infective Products Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Latin America OTC Anti-Infective Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America OTC Anti-Infective Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America OTC Anti-Infective Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa OTC Anti-Infective Products Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 64. Middle East and Africa OTC Anti-Infective Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa OTC Anti-Infective Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa OTC Anti-Infective Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. OTC Anti-Infective Products Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. OTC Anti-Infective Products Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiseptics
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva
  • Johnson & Johnson
  • NOVARTIS
  • MYLAN
  • Roche
  • Lingrui
  • Pfizer
  • CR SANJIU
  • GSK
  • Bayer
  • Sun Pharma
  • Gilead Sciences
  • Cipla
  • Bausch Health
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global OTC Anti-Infective Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global OTC Anti-Infective Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 OTC Anti-Infective Products Market by Type
  6. 1.3.1 Antiviral
  7. 1.3.2 Antibacterial
  8. 1.3.3 Antifungal
  9. 1.3.4 Antiseptics
  10. 1.3.5 Others
  11. 1.4 Global OTC Anti-Infective Products Market Size by Type
  12. 1.4.1 Global OTC Anti-Infective Products Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global OTC Anti-Infective Products Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global OTC Anti-Infective Products Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America OTC Anti-Infective Products Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe OTC Anti-Infective Products Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific OTC Anti-Infective Products Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America OTC Anti-Infective Products Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa OTC Anti-Infective Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 OTC Anti-Infective Products Industry Trends
  2. 2.2 OTC Anti-Infective Products Industry Drivers
  3. 2.3 OTC Anti-Infective Products Industry Opportunities and Challenges
  4. 2.4 OTC Anti-Infective Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by OTC Anti-Infective Products Revenue (2021-2026)
  2. 3.2 Global Top Players by OTC Anti-Infective Products Sales (2021-2026)
  3. 3.3 Global Top Players by OTC Anti-Infective Products Price (2021-2026)
  4. 3.4 Global OTC Anti-Infective Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Anti-Infective Products Major Company Production Sites & Headquarters
  6. 3.6 Global OTC Anti-Infective Products Company, Product Type & Application
  7. 3.7 Global OTC Anti-Infective Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Anti-Infective Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Anti-Infective Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Anti-Infective Products Tier 1, Tier 2, and Tier 3
4 OTC Anti-Infective Products Regional Status and Outlook
  1. 4.1 Global OTC Anti-Infective Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global OTC Anti-Infective Products Historic Market Size by Region
  3. 4.2.1 Global OTC Anti-Infective Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global OTC Anti-Infective Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global OTC Anti-Infective Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global OTC Anti-Infective Products Forecasted Market Size by Region
  7. 4.3.1 Global OTC Anti-Infective Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global OTC Anti-Infective Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global OTC Anti-Infective Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 OTC Anti-Infective Products by Application
  1. 5.1 OTC Anti-Infective Products Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global OTC Anti-Infective Products Market Size by Application
  6. 5.2.1 Global OTC Anti-Infective Products Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global OTC Anti-Infective Products Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global OTC Anti-Infective Products Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America OTC Anti-Infective Products Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe OTC Anti-Infective Products Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific OTC Anti-Infective Products Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America OTC Anti-Infective Products Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa OTC Anti-Infective Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva OTC Anti-Infective Products Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 NOVARTIS
  14. 6.3.1 NOVARTIS Company Information
  15. 6.3.2 NOVARTIS Business Overview
  16. 6.3.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
  18. 6.3.5 NOVARTIS Recent Developments
  19. 6.4 MYLAN
  20. 6.4.1 MYLAN Company Information
  21. 6.4.2 MYLAN Business Overview
  22. 6.4.3 MYLAN OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MYLAN OTC Anti-Infective Products Product Portfolio
  24. 6.4.5 MYLAN Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche OTC Anti-Infective Products Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Lingrui
  32. 6.6.1 Lingrui Company Information
  33. 6.6.2 Lingrui Business Overview
  34. 6.6.3 Lingrui OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lingrui OTC Anti-Infective Products Product Portfolio
  36. 6.6.5 Lingrui Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer OTC Anti-Infective Products Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 CR SANJIU
  44. 6.8.1 CR SANJIU Company Information
  45. 6.8.2 CR SANJIU Business Overview
  46. 6.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
  48. 6.8.5 CR SANJIU Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK OTC Anti-Infective Products Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 Bayer
  56. 6.10.1 Bayer Company Information
  57. 6.10.2 Bayer Business Overview
  58. 6.10.3 Bayer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bayer OTC Anti-Infective Products Product Portfolio
  60. 6.10.5 Bayer Recent Developments
  61. 6.11 Sun Pharma
  62. 6.11.1 Sun Pharma Company Information
  63. 6.11.2 Sun Pharma Business Overview
  64. 6.11.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
  66. 6.11.5 Sun Pharma Recent Developments
  67. 6.12 Gilead Sciences
  68. 6.12.1 Gilead Sciences Company Information
  69. 6.12.2 Gilead Sciences Business Overview
  70. 6.12.3 Gilead Sciences OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Gilead Sciences OTC Anti-Infective Products Product Portfolio
  72. 6.12.5 Gilead Sciences Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cipla OTC Anti-Infective Products Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Bausch Health
  80. 6.14.1 Bausch Health Company Information
  81. 6.14.2 Bausch Health Business Overview
  82. 6.14.3 Bausch Health OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bausch Health OTC Anti-Infective Products Product Portfolio
  84. 6.14.5 Bausch Health Recent Developments
  85. 6.15 Astellas Pharma
  86. 6.15.1 Astellas Pharma Company Information
  87. 6.15.2 Astellas Pharma Business Overview
  88. 6.15.3 Astellas Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Astellas Pharma OTC Anti-Infective Products Product Portfolio
  90. 6.15.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America OTC Anti-Infective Products Sales by Country
  2. 7.1.1 North America OTC Anti-Infective Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America OTC Anti-Infective Products Sales by Country (2021-2026)
  4. 7.1.3 North America OTC Anti-Infective Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America OTC Anti-Infective Products Market Size by Country
  6. 7.2.1 North America OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America OTC Anti-Infective Products Market Size by Country (2021-2026)
  8. 7.2.3 North America OTC Anti-Infective Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe OTC Anti-Infective Products Sales by Country
  2. 8.1.1 Europe OTC Anti-Infective Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe OTC Anti-Infective Products Sales by Country (2021-2026)
  4. 8.1.3 Europe OTC Anti-Infective Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe OTC Anti-Infective Products Market Size by Country
  6. 8.2.1 Europe OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe OTC Anti-Infective Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe OTC Anti-Infective Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific OTC Anti-Infective Products Sales by Country
  2. 9.1.1 Asia-Pacific OTC Anti-Infective Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific OTC Anti-Infective Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific OTC Anti-Infective Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific OTC Anti-Infective Products Market Size by Country
  6. 9.2.1 Asia-Pacific OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific OTC Anti-Infective Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific OTC Anti-Infective Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America OTC Anti-Infective Products Sales by Country
  2. 10.1.1 South America OTC Anti-Infective Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America OTC Anti-Infective Products Sales by Country (2021-2026)
  4. 10.1.3 South America OTC Anti-Infective Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America OTC Anti-Infective Products Market Size by Country
  6. 10.2.1 South America OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America OTC Anti-Infective Products Market Size by Country (2021-2026)
  8. 10.2.3 South America OTC Anti-Infective Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa OTC Anti-Infective Products Sales by Country
  2. 11.1.1 Middle East and Africa OTC Anti-Infective Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa OTC Anti-Infective Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa OTC Anti-Infective Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa OTC Anti-Infective Products Market Size by Country
  6. 11.2.1 Middle East and Africa OTC Anti-Infective Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa OTC Anti-Infective Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa OTC Anti-Infective Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 OTC Anti-Infective Products Value Chain Analysis
  2. 12.1.1 OTC Anti-Infective Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 OTC Anti-Infective Products Production Mode & Process
  7. 12.2 OTC Anti-Infective Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 OTC Anti-Infective Products Distributors
  10. 12.2.3 OTC Anti-Infective Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst